Nu-Tek BioSciences cuts the ribbon in its state-of-the-art manufacturing facility

AUSTIN, Minn., September 13, 2022 /PRNewswire/ — Nu-Tek Biosciences, an innovative manufacturer of industrial compounds used in the development and manufacture of pharmaceutical products, cut the ribbon on its purpose-built, state-of-the-art manufacturing facility last month.

The ribbon cutting event featured an array of VIP speakers including Austin Mayor Steve King and CEO of Nu-Tek Thomas Yezzi and a congratulatory message from MINNESOTA Governor Tim Walz. Expected from Frank JaskulkeVice President of Intelligence at the Medical Alley Association, the event also featured a drone video tour of the new manufacturing plant, a concert from Austin himself. Martin Zellar and The Gear Daddies, and a fireworks display.

In a visit before the opening, on August 18, MINNESOTA Senator Amy Klobuchar toured the one-of-a-kind facility, noting the importance of Nu-Tek’s plant and its capacity to mitigate supply chain risks with local manufacturing. Additionally, the Hormel Institute, an independent cancer research department within University of MinnesotaTalented CEO Tom Yezzi and Nu-Tek a commemorative artwork.

60,000 feet2 facility is the first dedicated, animal-free peptone and protein hydrolyzate production facility in United States. The facility is expected to be fully operational in October and will employ approximately 35 people. Even more jobs will be created as Nu-Tek executes the next phases of the business. Because the new facility was built specifically for Nu-Tek’s manufacturing capabilities, the plant’s design and engineering implemented safety measures that would be difficult to install in a legacy plant. This includes people flow, process flow, electronic record keeping and cross contamination prevention. Nu-Tek’s quality management system is ISO9001 certified. In addition, Nu-Tek has been able to incorporate tracking and testing of raw materials to better understand the performance of the final product.

After a competitive and extensive site selection process, Nu-Tek decided on this City of Austin for plant location. Yezzi cites Austin’s proximity to healthcare industry leaders, such as the Mayo Clinic Health System and the Hormel Institute, as key deciding factors for the location, as well as Austin’s rich manufacturing history. Approximately 85% of 45 million dollars the project was completed by MINNESOTA companies, with WisconsinBased on JCW Development and WDS Construction also on the design and construction team for the facility. The facility is spread over nine acres, with more space available for future expansion.

About Nu-Tek BioSciences

Nu-Tek BioSciences is an innovative manufacturer that develops and manufactures animal-free peptones and protein hydrolysates for leading companies in the biotechnology and pharmaceutical industries. The company’s product portfolio is used in a variety of applications ranging from mammalian cell culture to industrial fermentation. Nu-Tek is a best-in-class solution-based manufacturer that provides superior customer service and performance enhancing cell nutrition. The company’s manufacturing processes can be used to produce almost any peptone or hydrolyzate and have made Nu-Tek the leading option for custom manufacturing.

Media Agency Contact
James Choe
This is Nice LLC
[email protected]

Company headquarters
Nu-Tek BioSciences, LLC.
5400 Opportunity Ct., Suite 120
Minnetonka, MN 55343

Production facility
Nu-Tek BioSciences
1103 27th Avenue Northwest
Austin, MN 55912

T: 952-936-3600
E: [email protected]
www.nu-tekbiosciences.com

SOURCE Nu-Tek BioSciences

Leave a Comment